Difference in Impact of CYP2C19 Polymorphism on Platelet Reactivity and Clinical Outcomes Between Acute Coronary Syndrome (ACS) and Stable Angina

被引：0
|
作者：
Hokimoto, Seiji [1 ]
Akasaka, Tomonori [1 ]
Kaikita, Koichi [1 ]
Nakagawa, Kazuko [2 ]
Ogawa, Hisao [1 ]
机构：
[1] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto, Japan
[2] Kumamoto Univ, Div Pharmacol & Therapeut, Kumamoto, Japan
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Acute coronary syndromes; Pharmacogenetics; Percutaneous coronary intervention; Genetics;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16546
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effects of CYP2C19 Variants on Platelet Reactivity in Acute Stroke Patients Treated with Clopidogrel
    Lei, Qi
    Yang, Qian
    Wang, Qian
    Yang, Jiangcun
    Lv, Jianmeng
    Guo, Xiaomin
    Kang, Bei
    ANNALS OF NEUROLOGY, 2015, 78 : S28 - S28
  • [42] A Study On The Impact Of CYP2C19 Genotype And Platelet Reactivity Assay On Patients Undergoing PCI
    Chidambaram, Sundar
    Rath, Prathap C.
    Dixit, Byomakesh
    Rath, Pallavi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B87 - B87
  • [43] The Impact of CYP2C19 Polymorphisms on Clinical Outcomes of the Patients Treated with Clopidogrel
    Lee, Y.
    Kim, M.
    Kim, H.
    Lee, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 760 - 760
  • [44] Impact of Cyp2c19 Variants and Epoxyeicosatrienoic Acids on Microvascular Angina
    Akasaka, Tomonori
    Hokimoto, Seiji
    Ogawa, Hisao
    CIRCULATION, 2016, 134
  • [45] Impact of CYP2C19 Polymorphism on Platelet Function Tests and Coagulation and Inflammatory Biomarkers in Patients Undergoing Percutaneous Coronary Intervention
    Kaikita, Koichi
    Ono, Takamichi
    Iwashita, Satomi
    Nakayama, Naoki
    Sato, Koji
    Horio, Eiji
    Nakamura, Shinichi
    Tsujita, Kenichi
    Tayama, Shinji
    Hokimoto, Seiji
    Sakamoto, Tomohiro
    Nakao, Koichi
    Oshima, Shuichi
    Sugiyama, Seigo
    Ogawa, Hisao
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (01) : 64 - 76
  • [46] Association Between CYP2C19 Polymorphism and Depressive Symptoms
    Sim, Sarah C.
    Nordin, Linn
    Andersson, Therese M. -L.
    Virding, Susanne
    Olsson, Marita
    Pedersen, Nancy L.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (06) : 1160 - 1166
  • [47] The Frequency of the Minor Polymorphisms in the CYP2C19, VEGFR-2 Genes, and Clinical Outcomes in Russian and Buryat Patients with Acute Coronary Syndrome
    Zelenskaya, Elena M.
    Lifshits, Galina, I
    Nikolaev, Konstantin Yu
    Donirova, Oyuna S.
    Altayev, Vadim D.
    Apartsin, Konstantin A.
    Voronina, Elena N.
    Protasov, Konstantin, V
    Sychev, Dmitry A.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2020, 24 (06) : 338 - 342
  • [48] Impact of Esomeprazole on Platelet Reactivity and Clinical Outcome According to CYP2C19 Genotype in Coronary Heart Disease Patients during Dual Antiplatelet Therapy
    Hokimoto, Seiji
    Kaikita, Koichi
    Nakaawa, Kazuko
    Ogawa, Hisao
    CIRCULATION, 2014, 130
  • [49] CYP2C19 activity and cardiovascular risk factors in patients with an acute coronary syndrome
    Martinez-Quintana, Efren
    Rodriguez-Gonzalez, Fayna
    Maria Medina-Gil, Jose
    Garay-Sanchez, Paloma
    Tugores, Antonio
    MEDICINA CLINICA, 2017, 149 (06): : 235 - 239
  • [50] Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy
    Hokimoto, Seiji
    Akasaka, Tomonori
    Tabata, Noriaki
    Arima, Yuichiro
    Tsujita, Kenichi
    Sakamoto, Kenji
    Kaikita, Koichi
    Morita, Kazunori
    Kumagae, Naoki
    Yamamoto, Eiichiro
    Oniki, Kentaro
    Nakagawa, Kazuko
    Ogawa, Hisao
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1081 - 1086
12345